Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain

Nature Communications

Volumn 5, Issue , 2014, Pages

  Lau, Kelvin ^a   Van Petegem, Filip ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; MUTANT PROTEIN; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 2; RYANODINE RECEPTOR;

CALCIUM; CALORIMETRY; COUPLING; ION EXCHANGE; MUSCLE; MUTATION; SKELETON;

AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM TRANSPORT; CRYSTAL STRUCTURE; ELECTRON TOMOGRAPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISOTHERMAL TITRATION CALORIMETRY; LOSS OF FUNCTION MUTATION; MEMBRANE DEPOLARIZATION; NONHUMAN; PROTEIN DOMAIN; PROTEIN FOLDING; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; MOLECULAR DOCKING; MOLECULAR GENETICS; MOUSE; MUTATION; PROTEIN CONFORMATION; RABBIT;

AMINO ACID SEQUENCE; ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; HUMANS; MICE; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; RABBITS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84923339218     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6397     Document Type: Article

References (66)

1. Van Petegem, F. Ryanodine receptors: structure and function. J. Biol. Chem. 287, 31624-31632 (2012).
2. Takeshima, H. et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 339, 439-445 (1989).
3. Zorzato, F. et al. Molecular cloning of cDNA encoding human and rabbit forms of the Ca2 + release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 265, 2244-2256 (1990).
4. Otsu, K. et al. Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J. Biol. Chem. 265, 13472-13483 (1990).
5. Nakai, J. et al. Primary structure and functional expression from cDNA of the cardiac ryanodine receptor/calcium release channel. FEBS Lett. 271, 169-177 (1990).
6. Hakamata, Y., Nakai, J., Takeshima, H. & Imoto, K. Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain. FEBS Lett. 312, 229-235 (1992).
7. Ludtke, S. J., Serysheva, I. I., Hamilton, S. L. & Chiu, W. The pore structure of the closed RyR1 channel. Structure 13, 1203-1211 (2005).
8. Samso, M., Wagenknecht, T. & Allen, P. D. Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo-EM. Nat. Struct. Mol. Biol. 12, 539-544 (2005).
9. Samso, M., Feng, W., Pessah, I. N. & Allen, P. D. Coordinated movement of cytoplasmic and transmembrane domains of RyR1 on gating. PLoS Biol. 7, e85 (2009).
10. Kimlicka, L. & Van Petegem, F. The structural biology of ryanodine receptors. Sci. China Life Sci. 54, 712-724 (2011).
11. Van Petegem, F. Ryanodine receptors: allosteric ion channel giants. J. Mol. Biol. S0022-2836, 00419-00427 (2014).
12. Tung, C. C., Lobo, P. A., Kimlicka, L. & Van Petegem, F. The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule. Nature 468, 585-588 (2010).
13. Lobo, P. A., Kimlicka, L., Tung, C. C. & Van Petegem, F. The deletion of exon 3 in the cardiac ryanodine receptor is rescued by beta strand switching. Structure 19, 790-798 (2011).
14. Kimlicka, L., Lau, K., Tung, C. C. & Van Petegem, F. Disease mutations in the ryanodine receptor N-terminal region couple to a mobile intersubunit interface. Nat. Commun. 4, 1506 (2013).
15. Kimlicka, L. et al. The cardiac ryanodine receptor N-terminal region contains an anion binding site that is targeted by disease mutations. Structure 21, 1440-1449 (2013).
16. Lobo, P. A. & Van Petegem, F. Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations. Structure 17, 1505-1514 (2009).
17. Amador, F. J. et al. Crystal structure of type I ryanodine receptor amino-terminal beta-trefoil domain reveals a disease-associated mutation "hot spot" loop. Proc. Natl Acad. Sci. USA 106, 11040-11044 (2009).
18. Amador, F. J. et al. Type 2 ryanodine receptor domain A contains a unique and dynamic alpha-helix that transitions to a beta-strand in a mutant linked with a heritable cardiomyopathy. J. Mol. Biol. 425, 4034-4046 (2013).
19. Yuchi, Z., Lau, K. & Van Petegem, F. Disease mutations in the ryanodine receptor central region: crystal structures of a phosphorylation hot spot domain. Structure 20, 1201-1211 (2012).
20. Sharma, P. et al. Structural determination of the phosphorylation domain of the ryanodine receptor. FEBS J. 279, 3952-3964 (2012).
21. Endo, M., Tanaka, M. & Ogawa, Y. Calcium induced release of calcium from the sarcoplasmic reticulum of skinned skeletal muscle fibres. Nature 228, 34-36 (1970).
22. Fabiato, A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am. J. Physiol. 245, C1-14 (1983).
23. Rios, E. & Brum, G. Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle. Nature 325, 717-720 (1987).
24. Tanabe, T., Beam, K. G., Powell, J. A. & Numa, S. Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA. Nature 336, 134-139 (1988).
25. Block, B. A., Imagawa, T., Campbell, K. P. & Franzini-Armstrong, C. Structural evidence for direct interaction between the molecular components of the transverse tubule/sarcoplasmic reticulum junction in skeletal muscle. J. Cell Biol. 107, 2587-2600 (1988).
26. Adams, B. A., Tanabe, T., Mikami, A., Numa, S. & Beam, K. G. Intramembrane charge movement restored in dysgenic skeletal muscle by injection of dihydropyridine receptor cDNAs. Nature 346, 569-572 (1990).
27. Takekura, H., Bennett, L., Tanabe, T., Beam, K. G. & Franzini-Armstrong, C. Restoration of junctional tetrads in dysgenic myotubes by dihydropyridine receptor cDNA. Biophys. J. 67, 793-803 (1994).
28. Nakai, J. et al. Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 380, 72-75 (1996).
29. Avila, G. & Dirksen, R. T. Functional impact of the ryanodine receptor on the skeletal muscle L-type Ca(2 + ) channel. J. Gen. Physiol. 115, 467-480 (2000).
30. Tanabe, T., Beam, K. G., Adams, B. A., Niidome, T. & Numa, S. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature 346, 567-569 (1990).
31. Nakai, J., Tanabe, T., Konno, T., Adams, B. & Beam, K. G. Localization in the II-III loop of the dihydropyridine receptor of a sequence critical for excitation-contraction coupling. J. Biol. Chem. 273, 24983-24986 (1998).
32. Kugler, G., Weiss, R. G., Flucher, B. E. & Grabner, M. Structural requirements of the dihydropyridine receptor alpha1S II-III loop for skeletal-type excitation-contraction coupling. J. Biol. Chem. 279, 4721-4728 (2004).
33. Nakai, J., Sekiguchi, N., Rando, T. A., Allen, P. D. & Beam, K. G. Two regions of the ryanodine receptor involved in coupling with L-type Ca2+ channels. J. Biol. Chem. 273, 13403-13406 (1998).
34. Protasi, F. et al. Multiple regions of RyR1 mediate functional and structural interactions with alpha(1S)-dihydropyridine receptors in skeletal muscle. Biophys. J. 83, 3230-3244 (2002).
35. Sheridan, D. C. et al. Bidirectional signaling between calcium channels of skeletal muscle requires multiple direct and indirect interactions. Proc. Natl Acad. Sci. USA 103, 19760-19765 (2006).
36. Perez, C. F., Mukherjee, S. & Allen, P. D. Amino acids 1-1, 680 of ryanodine receptor type 1 hold critical determinants of skeletal type for excitation-contraction coupling. Role of divergence domain D2. J. Biol. Chem. 278, 39644-39652 (2003).
37. Cui, Y. et al. A dihydropyridine receptor alpha1s loop region critical for skeletal muscle contraction is intrinsically unstructured and binds to a SPRY domain of the type 1 ryanodine receptor. Int. J. Biochem. Cell Biol. 41, 677-686 (2009).
38. Tae, H. S. et al. Molecular recognition of the disordered dihydropyridine receptor II-III loop by a conserved spry domain of the type 1 ryanodine receptor. Clin. Exp. Pharmacol. Physiol. 36, 346-349 (2009).
39. Tae, H. S. et al. Cyclisation of the intrinsically disordered {alpha}1s dihydropyridine receptor II-III loop enhances secondary structure and in vitro function. J. Biol. Chem. 286, 22589-22599 (2011).
40. Tae, H. et al. The elusive role of the SPRY2 domain in RyR1. Channels 5, 148-160 (2011).
41. Leong, P. & MacLennan, D. H. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor. J. Biol. Chem. 273, 7791-7794 (1998).
42. Peralvarez-Marin, A. et al. 3D mapping of the SPRY2 domain of ryanodine receptor 1 by single-particle cryo-EM. PLoS ONE 6, e25813 (2011).
43. Noboru, F. et al. in Circulation 114, 165 (2006).
44. Tang, Y., Tian, X., Wang, R., Fill, M. & Chen, S. R. Abnormal termination of Ca2 + release is a common defect of RyR2 mutations associated with cardiomyopathies. Circ. Res. 110, 968-977 (2012).
45. Bohm, J. et al. An integrated diagnosis strategy for congenital myopathies. PLoS ONE 8, e67527 (2013).
46. Klein, A. et al. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies. Hum. Mutat. 33, 981-988 (2012).
47. Tammaro, A. et al. Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families. Clin. Genet. 79, 438-447 (2011).
48. Robinson, R., Carpenter, D., Shaw, M. A., Halsall, J. & Hopkins, P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum. Mutat. 27, 977-989 (2006).
49. Gonsalves, S. G. et al. Using exome data to identify malignant hyperthermia susceptibility mutations. Anesthesiology 119, 1043-1053 (2013).
50. Wriggers, W., Milligan, R. A. & McCammon, J. A. Situs: a package for docking crystal structures into low-resolution maps from electron microscopy. J. Struct. Biol. 125, 185-195 (1999).
51. Zhong, X. et al. Conformational dynamics inside amino-terminal disease hotspot of ryanodine receptor. Structure 21, 2051-2060 (2013).
52. Liu, Z., Zhang, J., Wang, R., Wayne Chen, S. R. & Wagenknecht, T. Location of divergent region 2 on the three-dimensional structure of cardiac muscle ryanodine receptor/calcium release channel. J. Mol. Biol. 338, 533-545 (2004).
53. Wang, R. et al. Localization of the Dantrolene-binding sequence near the FK506-binding protein-binding site in the three-dimensional structure of the ryanodine receptor. J. Biol. Chem. 286, 12202-12212 (2011).
54. Mahalingam, M. et al. Structural mapping of divergent regions in the type 1 ryanodine receptor using fluorescence resonance energy transfer. Structure 22, 1322-1332 (2014).
55. Gillard, E. F. et al. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 11, 751-755 (1991).
56. Jungbluth, H., Sewry, C. A. & Muntoni, F. What's new in neuromuscular disorders? The congenital myopathies. Eur. J. Paediatr. Neurol. 7, 23-30 (2003).
57. Priori, S. G. et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103, 196-200 (2001).
58. Medeiros-Domingo, A. et al. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. J. Am. Coll. Cardiol. 54, 2065-2074 (2009).
59. Tateishi, H. et al. Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2 + leak in failing hearts. Cardiovasc. Res. 81, 536-545 (2009).
60. Ludtke, S. J. & Serysheva, I. I. Single-particle cryo-EM of calcium release channels: structural validation. Curr. Opin. Struct. Biol. 23, 755-762 (2013).
61. Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125-132 (2010).
62. Terwilliger, T. C. et al. Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard. Acta Crystallogr. D Biol. Crystallogr. 65, 582-601 (2009).
63. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221 (2010).
64. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
65. Nettleship, J. E., Brown, J., Groves, M. R. & Geerlof, A. Methods for protein characterization by mass spectrometry, thermal shift (ThermoFluor) assay, and multiangle or static light scattering. Methods Mol. Biol. 426, 299-318 (2008).
66. Edelhoch, H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6, 1948-1954 (1967).